Abbott Laboratories (ABT) Earnings Call Analysis

NYSE · Healthcare · Medical Devices

24/25

Growth 5 Margin 5 Expansion 5 Platform 4 Financial 5

latest quarter score

Earnings Reports

24
Abbott (ABT) Q2 2026: Four Growth Engines Drive 80% of Second-Half Acceleration
July 16, 2026
25
Abbott (ABT) Q1 2026: Exact Sciences Adds $3B Growth Engine, Diagnostics and MedTech Set for H2 Acceleration
April 16, 2026
24
Abbott (ABT) Q4 2025: Medical Device Growth Hits 10.5% as Nutrition Recalibration Weighs on Outlook
January 22, 2026
23
Abbott (ABT) Q3 2025: Medical Devices Surge 12.5% as Portfolio Expansion Drives Durable Growth
October 15, 2025
24
Abbott (ABT) Q2 2025: Medical Devices Surge 12% as Diagnostics Face $1B Headwind
July 18, 2025
25
Abbott (ABT) Q1 2025: Margin Expansion and Diversified Growth Offset Tariff Uncertainty
June 10, 2025
Abbott (ABT) Q3 2024: MedTech Surges 13% as Libre, Structural Heart Drive Portfolio Momentum
October 16, 2024
Abbott (ABT) Q2 2024: Medical Devices Surge 12% as Margin Expansion Outpaces Peers
July 18, 2024
Abbott (ABT) Q1 2024: Medical Devices Surge 14%, Propelling Guidance Raise and Margin Expansion
April 17, 2024
Abbott (ABT) Q4 2023: Base Business Grows 11% as Pipeline Delivers New $3B Opportunity
January 24, 2024
21
Abbott (ABT) Q3 2023: Base Business Grows 14% as Freestyle Libre Surges, Margin Expansion in Focus
October 18, 2023
Abbott (ABT) Q2 2023: Base Business Organic Sales Jump 11.5% as Pipeline and Recovery Drive Momentum
July 20, 2023
Abbott (ABT) Q1 2023: Base Business Accelerates to 10% Growth as COVID Testing Declines
April 19, 2023

Browse all companies